Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone

IsraelCompletedPHASE3

Conditions

Hepatocellular Carcinoma (HCC)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Alabama, Birmingham, Alabama, United States

  • Mayo Clinic Arizona, Scottsdale, Arizona, United States

  • UC Irvine Medical Center, Orange, California, United States

  • Stanford University School of Medicine, Palo Alto, California, United States

  • University of Florida Shands Hospital, Gainesville, Florida, United States

  • University of Chicago, Chicago, Illinois, United States

  • University of Kansas Cancer Center, Kansas City, Kansas, United States

  • University of Louisville, Louisville, Kentucky, United States

  • Tulane University Health Sciences Center, New Orleans, Louisiana, United States

  • Mercy Medical Center, Inc., Baltimore, Maryland, United States

  • University of Minnesota, Minneapolis, Minnesota, United States

  • Kansas City Research Institute, Kansas City, Missouri, United States

  • Saint Louis University, St Louis, Missouri, United States

  • Washington University School of Medicine, St Louis, Missouri, United States

  • Billings Clinic, Billings, Montana, United States

  • Morristown Medical Center, Morristown, New Jersey, United States

  • St. Joseph's Hospital, Paterson, New Jersey, United States

  • Ohio State University, Columbus, Ohio, United States

  • Hospital of The University of Pennsylvania, Philadelphia, Pennsylvania, United States

  • Rhode Island Hospital, Providence, Rhode Island, United States

  • University of Tennessee Medical Center, Knoxville, Tennessee, United States

  • University of Texas Southwestern Medical Center, Dallas, Texas, United States

  • Benaroya Research Institute at Virginia Mason Hospital, Seattle, Washington, United States

  • Site No. 8409, Adelaide, Australia

  • Site No. 8412, Adelaide, Australia

  • Site No. 8403, Brisbane, Australia

  • Site No. 8401, Camperdown, Australia

  • Site No. 8407, Clayton, Australia

  • Site No. 8406, Concord, Australia

  • Site No. 8408, Fitzroy, Australia

  • Site No. 8405, Footscray, Australia

  • Site No. 8414, Heidelberg, Australia

  • Site No. 8411, Melbourne, Australia

  • Site No. 8402, Parkville, Australia

  • Site No. 8415, Perth, Australia

  • Site No. 8413, Sydney, Australia

  • University of Alberta Hospital, Edmonton, Alberta, Canada

  • Juravinski Cancer Centre, Hamilton, Ontario, Canada

  • Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

  • Site 8829, Changchun, China

  • Site No. 8821, Changsha, China

  • Site 8811, Fuzhou, China

  • Site 8820, Fuzhou, China

  • Site No.8816, Guangdong, China

  • Site 8827, Guangzhou, China

  • Site No.8828, Guangzhou, China

  • Site 8832, Hangzhou, China

  • Site No. 8802, Harbin, China

  • Site 8805, Hefei, China

  • Site No. 8808, Hefei, China

  • Site No.8815, Hefei, China

  • Site No. 8801, Nanjing, China

  • Site 8833, Qingdao, China

  • Site 8806, Shanghai, China

  • Site 8822, Shanghai, China

  • Site 8831, Shanghai, China

  • Site No. 8823, Xi'an, China

  • Site No. 8825, Xi'an, China

  • Site No. 9013, Bondy, France

  • Site No. 9005, Bordeaux, France

  • Site No. 9003, Créteil, France

  • Site No. 9006, Lille, France

  • Site 9012, Montpellier, France

  • Site No. 9008, Nantes, France

  • Site No. 9010, Nice, France

  • Site No. 9007, Paris, France

  • Site No. 9014, Paris, France

  • Site No. 9011, Rennes, France

  • Site No. 9001, Strasbourg, France

  • Site No. 9002, Toulouse, France

  • Site No. 9009, Vandœuvre-lès-Nancy, France

  • Site No. 9111, Aachen, Germany

  • Site No. 9113, Bonn, Germany

  • Site No. 9109, Dresden, Germany

  • Site No. 9108, Frankfurt am Main, Germany

  • Site No. 9106, Hamburg, Germany

  • Site No 9105, Hannover, Germany

  • Site No. 9112, Heidelberg, Germany

  • Site No. 9101, Mainz, Germany

  • Site No. 9102, München, Germany

  • Site No. 9104, Tübingen, Germany

  • Site No. 9110, Ulm, Germany

  • Site No. 8601, Hong Kong, Hong Kong

  • Site No. 9707, Afula, Israel

  • Site 9704, Haifa, Israel

  • Site No. 9702, Haifa, Israel

  • Site No. 9705, Jerusalem, Israel

  • Site No. 9703, Ramat Gan, Israel

  • Site No. 9706, Tel Aviv, Israel

  • Site No.9205, Modena, Italy

  • Site No. 9204, Naples, Italy

  • Site No. 9201, Palermo, Italy

  • Site No. 9203, Parma, Italy

  • Auckland City Hospital, Auckland, New Zealand, New Zealand

  • Site No. 8902, Christchurch, New Zealand

  • Site No. 9404, Coimbra, Portugal

  • Site No. 9405, Coimbra, Portugal

  • Site No. 9403, Lisbon, Portugal

  • Site No. 9401, Porto, Portugal

  • Site No. 9402, Porto, Portugal

  • Site 8702, Singapore, Singapore

  • Site 8703, Singapore, Singapore

  • Site No. 8701, Singapore, Singapore

  • Site No. 8208, Ansan, South Korea

  • Site No. 8211, Bucheon-si, South Korea

  • Site No. 8201, Busan, South Korea

  • Site 8216, Daegu, South Korea

  • Site No. 8207, Daegu, South Korea

  • Site No. 8213, Daegu, South Korea

  • Site No. 8220, Daegu, South Korea

  • Site 8224, Goyang, South Korea

  • Site No. 8221, Jinju, South Korea

  • Site No. 8218, Pusan, South Korea

  • Site No. 8222, Seongnam, South Korea

  • Site No. 8219, Seongnam-si, South Korea

  • Site No. 8202, Seoul, South Korea

  • Site No. 8203, Seoul, South Korea

  • Site No. 8205, Seoul, South Korea

  • Site No. 8209, Seoul, South Korea

  • Site No. 8212, Seoul, South Korea

  • Site No. 8215, Seoul, South Korea

  • Site No. 8223, Seoul, South Korea

  • Site No. 8210, Suwon, South Korea

  • Site No. 8217, Ulsan, South Korea

  • Site No. 8305, Kaohsiung City, Taiwan

  • Site No. 8307, Linkou District, Taiwan

  • Site No. 8306, Taichung, Taiwan

  • Site No. 8302, Tainan, Taiwan

  • Site No. 8301, Taipei, Taiwan

  • Site No. 8303, Taipei, Taiwan

  • Site No. 8502, Bangkok, Thailand

  • Site No. 8505, Bangkok, Thailand

  • Site No. 8503, Chiang Mai, Thailand

  • Site No. 8507, Hat Yai, Thailand

  • Site No. 8501, Khon Kaen, Thailand

  • Site No. 8506, Phitsanulok, Thailand

  • Site No. 9501, Birmingham, United Kingdom

  • Site No. 9505, Guildford, United Kingdom

  • Site No. 9503, Leeds, United Kingdom

  • Site No. 9502, London, United Kingdom

  • Site No. 9504, London, United Kingdom

  • Site No. 9506, London, United Kingdom

Study leads
  • SillaJen Medical

    Study Director

    SillaJen, Inc.